Life Biosciences has received FDA clearance to begin a first-in-human Phase 1 clinical trial of ER-100, a gene therapy ...

Could this work to prevent blindness and eventually turn back the clock in other organs too?

Cellular reprogramming is the hottest topic in longevity science, with tech titans like Sam Altman investing in it. It's now being tested in humans.

First human gets experimental gene shot to rewind ageing cells in the eye Life Biosciences has dosed its first patient with ER-100, a treatment that uses partial cellular reprogramming to target ...

Today, more people are living past 100 than ever before — even though the maximum human lifespan hasn't moved past 115 years.

A groundbreaking human trial of ER-100, a cellular reprogramming therapy, has begun, testing whether damaged eye cells can be rejuvenated and potentially opening a new chapter in the science of aging.

Pleased to announce the first patient has been dosed in our Phase 1 clinical trial, evaluating our lead candidate for optic ...

Blindness itself might become, at least in certain cases, partially reversible. This potential future stems from one of the ...

Life Biosciences says it just dosed its first patient in an FDA-approved clinical trial to reverse age-related blindness.

You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. A first-of-its-kind shot that promises to reverse aging was just injected into a human body. It's a ...

A Boston biotech company has administered what researchers are describing as the first human dose of a cellular rejuvenation drug, a milestone in the effort to treat age-related disease at the ...

Promising mouse studies and billions of dollars in funding are stoking excitement. But we’ve been here before.